Albireo Pharma, Inc.
Albireo Pharma, Inc.（ALBO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
albo · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2023年12月4日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$48.00
Consensus
$44.00
-0.3% upside
Low
$42.00
Median: $42 · Last Close: $44.15
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$44.00
-0.3% upside
High Target
$48
8.7%
Low Target
$42
-4.9%
Current Price
$44.15
as of today
Based on analyst price targets, the ALBO stock price prediction for the next 12 months ranges from $42 to $48. The consensus ALBO price forecast of $44.00 implies -0.3% upside from the current price of $44.15.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $44.16 | ↑ 0.01% |
1-day model range: $44.11–$44.2. Peak: $44.2 (+0.01%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALBO · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-02-15 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2023-01-11 | Cowen & Co. | Downgrade ↓ | Outperform→Perform |
| 2023-01-11 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-01-11 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2023-01-10 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-01-09 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2022-10-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-10-12 | Baird | Maintains | Outperform→Outperform |
| 2022-09-08 | Guggenheim | Maintains | Buy→Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Albireo Pharma, Inc. (ALBO) stock. Of the recent 33 rating actions, 0 were upgrades and 5 were downgrades. 12 analysts currently cover ALBO.
分析师推荐趋势
ALBO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast ALBO EPS of $— for the current fiscal year, based on estimates from 0 analysts. The ALBO revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ALBO 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ALBO 的共识目标价为 $44.00（-0.3% 上行空间），分析师共识为 Buy。
ALBO 的短期预测（明日）为 $44.16（+0.01%）。
Albireo Pharma, Inc. 在 NASDAQ 上市，代码 ALBO。ALBO 在 2027 年的整体展望偏积极，在覆盖分析师中约 58% 对应 Buy 共识。
常见问题
ALBO 预测 · 8 个问题根据 12 位华尔街分析师，ALBO 的 12 个月平均目标价为 $44.00，最高 $48.00、最低 $42.00。若有图表，中位目标价可在上方查看。相对当前价 $44.15，隐含约 -0.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.